Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Biomed Pharmacother. 2023 Jul;163:114849. doi: 10.1016/j.biopha.2023.114849. Epub 2023 May 10.
Acute kidney injury (AKI) is a major health concern owing to its high morbidity and mortality rates, to which there are no drugs or treatment methods, except for renal replacement therapy. Therefore, identifying novel therapeutic targets and drugs for treating AKI is urgent. Ferroptosis is an iron-dependent and lipid-peroxidation-driven regulatory form of cell death and is closely associated with the occurrence and development of AKI. Traditional Chinese medicine (TCM) has unique advantages in treating AKI due to its natural origin and efficacy. In this review, we summarize the mechanisms underlying ferroptosis and its role in AKI, and TCM compounds that play essential roles in the prevention and treatment of AKI by inhibiting ferroptosis. This review suggests ferroptosis as a potential therapeutic target for AKI, and that TCM compounds show broad prospects in the treatment of AKI by targeting ferroptosis.
急性肾损伤(AKI)是一个主要的健康关注点,因为它具有高发病率和死亡率,除了肾脏替代疗法外,目前尚无药物或治疗方法。因此,寻找治疗 AKI 的新的治疗靶点和药物是迫切的。铁死亡是一种铁依赖性和脂质过氧化驱动的细胞死亡调节形式,与 AKI 的发生和发展密切相关。中药(TCM)由于其天然来源和疗效,在治疗 AKI 方面具有独特的优势。在这篇综述中,我们总结了铁死亡的机制及其在 AKI 中的作用,以及 TCM 化合物通过抑制铁死亡在预防和治疗 AKI 中发挥的重要作用。这篇综述表明铁死亡可能是 AKI 的一个潜在治疗靶点,而 TCM 化合物通过靶向铁死亡显示出在治疗 AKI 方面的广阔前景。
Biomed Pharmacother. 2023-7
Phytomedicine. 2024-7-25
Zhongguo Fei Ai Za Zhi. 2024-3-20
Cell Death Dis. 2022-2-24
Biomed Pharmacother. 2022-12
Mol Cell Biochem. 2025-2
Oxid Med Cell Longev. 2022
Front Pharmacol. 2024-6-4
Naunyn Schmiedebergs Arch Pharmacol. 2024-10
Front Pharmacol. 2024-2-14
Front Pharmacol. 2024-1-16
Signal Transduct Target Ther. 2023-12-10